Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 3
1987 6
1988 6
1989 9
1990 8
1991 13
1992 13
1993 16
1994 9
1995 16
1996 6
1997 9
1998 6
1999 5
2000 9
2001 6
2002 6
2003 7
2004 6
2005 5
2006 6
2007 8
2008 5
2009 4
2010 7
2011 10
2012 9
2013 11
2014 7
2015 6
2016 4
2017 1
2018 4
2019 3
2020 4
2021 5
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
Tung R, Xue Y, Chen M, Jiang C, Shatz DY, Besser SA, Hu H, Chung FP, Nakahara S, Kim YH, Satomi K, Shen L, Liang E, Liao H, Gu K, Jiang R, Jiang J, Hori Y, Choi JI, Ueda A, Komatsu Y, Kazawa S, Soejima K, Chen SA, Nogami A, Yao Y; PAUSE-SCD Investigators. Tung R, et al. Circulation. 2022 Jun 21;145(25):1839-1849. doi: 10.1161/CIRCULATIONAHA.122.060039. Epub 2022 May 4. Circulation. 2022. PMID: 35507499 Free article. Clinical Trial.
A statistically significant reduction in both ICD shocks (10.0% versus 24.6%; P=0.03) and antitachycardia pacing (16.2% versus 32.8%; P=0.04) was observed in patients who underwent ablation compared with control. No differences in cardiovascular hospitalization (32.0% vers …
A statistically significant reduction in both ICD shocks (10.0% versus 24.6%; P=0.03) and antitachycardia pacing (16.2% versus 32.8%; P=0.04 …
Ablation of ventricular arrhythmias.
Sadek MM, Marchlinski FE. Sadek MM, et al. Trends Cardiovasc Med. 2014 Oct;24(7):296-304. doi: 10.1016/j.tcm.2014.07.002. Epub 2014 Jul 11. Trends Cardiovasc Med. 2014. PMID: 25218675 Review.
Ventricular arrhythmias (VAs) commonly occur in patients with structural heart disease and may present as ventricular premature depolarizations (VPDs), monomorphic ventricular tachycardia (VT), or polymorphic VT/ventricular fibrillation. ...
Ventricular arrhythmias (VAs) commonly occur in patients with structural heart disease and may present as ventricular premature depolarizati …
Vasovagal Responses to Human Monomorphic Ventricular Tachycardia: Hemodynamic Implications From Sinus Rate Analysis.
Pujol-Lopez M, Du Fay de Lavallaz J, Rangan P, Beaser A, Aziz Z, Upadhyay GA, Nayak H, Weiss JP, Zawaneh M, Bai R, Su W, Tung R. Pujol-Lopez M, et al. J Am Coll Cardiol. 2023 Sep 12;82(11):1096-1105. doi: 10.1016/j.jacc.2023.06.033. J Am Coll Cardiol. 2023. PMID: 37673510

A significantly higher prevalence of inappropriate SR responses was observed during untolerated VT (sustained VT requiring cardioversion within 150 seconds) compared with tolerated VT (84% vs 34%; P < 0.001). ...CONCLUSIONS: Nearly one-half of VT episodes are associated

…
A significantly higher prevalence of inappropriate SR responses was observed during untolerated VT (sustained VT requiring cardiovers …
The diagnosis and management of ventricular arrhythmias.
Roberts-Thomson KC, Lau DH, Sanders P. Roberts-Thomson KC, et al. Nat Rev Cardiol. 2011 Jun;8(6):311-21. doi: 10.1038/nrcardio.2011.15. Epub 2011 Feb 22. Nat Rev Cardiol. 2011. PMID: 21343901 Review.
The term 'ventricular arrhythmias' incorporates a wide spectrum of abnormal cardiac rhythms, from single premature ventricular complexes to sustained monomorphic ventricular tachycardia (VT), polymorphic VT, and ventricular fibrillation. ...
The term 'ventricular arrhythmias' incorporates a wide spectrum of abnormal cardiac rhythms, from single premature ventricular complexes to …
Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy.
Cui L, Tse G, Zhao Z, Bazoukis G, Letsas KP, Korantzopoulos P, Roever L, Li G, Liu T. Cui L, et al. Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12638. doi: 10.1111/anec.12638. Epub 2019 Feb 9. Ann Noninvasive Electrocardiol. 2019. PMID: 30737990 Free PMC article. Review.
LV apical aneurysms are present in more than 20% MVOHCM cases and has been identified as an independent predictor of potentially lethal arrhythmic events, including non-sustained or sustained ventricular tachycardia (VT), and ventricular fibrillation (VF), as well as SCD. …
LV apical aneurysms are present in more than 20% MVOHCM cases and has been identified as an independent predictor of potentially leth …
Catheter ablation for monomorphic ventricular tachycardia in Brugada syndrome patients: detailed characteristics and long-term follow-up.
Tokioka S, Fukamizu S, Kitamura T, Miyazawa S, Kawamura I, Hojo R, Sakurada H, Hiraoka M. Tokioka S, et al. J Interv Card Electrophysiol. 2020 Jan;57(1):97-103. doi: 10.1007/s10840-019-00620-0. Epub 2019 Oct 12. J Interv Card Electrophysiol. 2020. PMID: 31606866
PURPOSE: Brugada syndrome (BrS) is a risk of sudden cardiac death due to polymorphic ventricular tachycardia and ventricular fibrillation with unusual monomorphic ventricular tachycardia (MVT). Detailed characteristics of MVT and long-term outcome of catheter …
PURPOSE: Brugada syndrome (BrS) is a risk of sudden cardiac death due to polymorphic ventricular tachycardia and ventricular fibrillation wi …
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Mazzanti A, Ng K, Faragli A, Maragna R, Chiodaroli E, Orphanou N, Monteforte N, Memmi M, Gambelli P, Novelli V, Bloise R, Catalano O, Moro G, Tibollo V, Morini M, Bellazzi R, Napolitano C, Bagnardi V, Priori SG. Mazzanti A, et al. J Am Coll Cardiol. 2016 Dec 13;68(23):2540-2550. doi: 10.1016/j.jacc.2016.09.951. J Am Coll Cardiol. 2016. PMID: 27931611 Free article.

Cumulative probability of a first LAE at follow-up was 14% at 5 years, 23% at 10 years, and 30% at 15 years. Higher risk of LAE was predicted by atrial fibrillation (hazard ratio [HR]: 4.38; p = 0.002), syncope (HR: 3.36; p < 0.001), participation in strenuous exercise

…
Cumulative probability of a first LAE at follow-up was 14% at 5 years, 23% at 10 years, and 30% at 15 years. Higher risk of LAE was predi …
Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.
Rodríguez-Mañero M, Sacher F, de Asmundis C, Maury P, Lambiase PD, Sarkozy A, Probst V, Gandjbakhch E, Castro-Hevia J, Saenen J, Fukushima Kusano K, Rollin A, Arbelo E, Valderrábano M, Arias MA, Mosquera-Pérez I, Schilling R, Chierchia GB, García-Bolao I, García-Seara J, Hernandez-Ojeda J, Kamakura T, Martínez-Sande L, González-Juanatey JR, Haïssaguerre M, Brugada J, Brugada P. Rodríguez-Mañero M, et al. Heart Rhythm. 2016 Mar;13(3):669-82. doi: 10.1016/j.hrthm.2015.10.038. Epub 2015 Oct 29. Heart Rhythm. 2016. PMID: 26538325
BACKGROUND: Isolated cases of monomorphic ventricular tachycardia (MVT) in patients with Brugada syndrome (BrS) have been reported. ...During a mean follow-up of 69.4 54.3 months, 114 patients (13.7%) experienced at least 1 appropriate ICD intervention, with …
BACKGROUND: Isolated cases of monomorphic ventricular tachycardia (MVT) in patients with Brugada syndrome (BrS) have be …
Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes.
Wang W, Gasperetti A, Sears SF, Tichnell C, Murray B, Tandri H, James CA, Calkins H. Wang W, et al. JACC Clin Electrophysiol. 2023 Mar;9(3):394-402. doi: 10.1016/j.jacep.2022.09.020. Epub 2022 Oct 31. JACC Clin Electrophysiol. 2023. PMID: 36328892 Free article.
METHODS: Patients with a subcutaneous ICD (n = 57) were matched to patients with a transvenous ICD (n = 88) based on sex, proband status, primary prevention or secondary prevention, monomorphic ventricular tachycardia before implantation, and year of implanta …
METHODS: Patients with a subcutaneous ICD (n = 57) were matched to patients with a transvenous ICD (n = 88) based on sex, proband status, pr …
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE, van der Stuijt W, Delnoy PPHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, Smeding L, Tijssen JGP, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Jansen WPJ, Whinnet ZI, Nordbeck P, Knaut M, Philbert BT, van Opstal JM, Chicos AB, Allaart CP, Borger van der Burg AE, Clancy JF, Dizon JM, Miller MA, Nemirovsky D, Surber R, Upadhyay GA, Weiss R, de Weger A, Wilde AAM, Olde Nordkamp LRA; PRAETORIAN Investigators‡. Knops RE, et al. Circulation. 2022 Feb;145(5):321-329. doi: 10.1161/CIRCULATIONAHA.121.057816. Epub 2021 Nov 14. Circulation. 2022. PMID: 34779221 Free article. Clinical Trial.
In contrast to TV-ICD, S-ICD cannot provide antitachycardia pacing for monomorphic ventricular tachycardia. This prespecified secondary analysis evaluates appropriate therapy and whether antitachycardia pacing reduces the number of appropriate shocks. ...Pati …
In contrast to TV-ICD, S-ICD cannot provide antitachycardia pacing for monomorphic ventricular tachycardia. This prespe …
247 results